US regulatory status: approved. Mechanism: Diagnostic agent.
- Mechanism
- Diagnostic agent
pharma · Total Laryngectomy · Breast Cancer · ATOS
ATOSSA THERAPEUTICS
ATOSSA THERAPEUTICS, INC.
ATOSSA THERAPEUTICS drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Torrance, USA HQ
2019 Founded
36 Employees
Public company Type
ATOS · NYSE Ticker
Company details
- Status
- Public
- HQ
- Torrance, USA
- Founded
- 2019
- Employees
- 36
- Programs
- 10
- Drugs
- 5
- Patents
- 8
ATOSSA THERAPEUTICS pipeline
Portfolio lens on 5 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
ATOSSA THERAPEUTICS drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
epinephrine
Cardiovascular system (C01)US regulatory status: approved. Molecular target: Adrenergic receptor.
- Target
- Adrenergic receptor
- Mechanism
- Adrenergic receptor agonist
-
US regulatory status: approved. Molecular target: Bacterial 70S ribosome.
- Target
- Bacterial 70S ribosome
- Mechanism
- Bacterial 70S ribosome inhibitor
-
fulvestrant
Antineoplastic and immunomodulating agents (L02)US regulatory status: approved. Molecular target: Estrogen receptor.
- Target
- Estrogen receptor
- Mechanism
- Estrogen receptor antagonist
-
US regulatory status: approved. Molecular target: Progesterone receptor.
- Target
- Progesterone receptor
- Mechanism
- Progesterone receptor agonist